BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8014861)

  • 1. Decreased elimination of drug in the presence of alpha-1-acid glycoprotein is related to a reduced hepatocyte uptake.
    Qin M; Nilsson M; Oie S
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1176-81. PubMed ID: 8014861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
    Oie S; Fiori F
    J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased elimination of unbound prazosin in the presence of alpha 1-acid glycoprotein in the rat in vivo.
    Oie S; Fiori F; Chiang J
    J Pharmacol Exp Ther; 1987 Jun; 241(3):934-8. PubMed ID: 3598910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic activity of prazosin is decreased by alpha-1-acid glycoprotein in vivo.
    Chiang J; Oie S
    J Pharmacol Exp Ther; 1990 Jul; 254(1):324-9. PubMed ID: 2164099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
    Urien S; Morin D; Tillement JP
    J Pharmacol Exp Ther; 1989 Feb; 248(2):781-5. PubMed ID: 2918479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of binding protein surface charge on palmitate uptake by hepatocyte suspensions.
    Burczynski FJ; Wang GQ; Hnatowich M
    Br J Pharmacol; 1997 Apr; 120(7):1215-20. PubMed ID: 9105695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.
    Sager G; Jaeger R; Little C
    Br J Clin Pharmacol; 1989 Feb; 27(2):229-34. PubMed ID: 2713217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of altered albumin concentrations on elimination of unbound prazosin in vivo in the rat and in the isolated perfused rat liver.
    Oie S; Yang YH
    J Pharm Sci; 1988 Nov; 77(11):948-51. PubMed ID: 3225755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    Mazoit JX; Cao LS; Samii K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.
    Pentel PR; Keyler DE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1061-6. PubMed ID: 3418509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of prazosin to alpha 1-acid glycoprotein and albumin: effect of protein purity and concentrations.
    Sager G; Jaeger R; Little C
    Pharmacol Toxicol; 1989 Apr; 64(4):365-8. PubMed ID: 2748545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of serum protein binding of felodipine.
    Valle M; Esteban M; Rodríguez-Sasiaín JM; Calvo R; Aguirre C
    Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):73-88. PubMed ID: 8948016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does alpha 1-acid glycoprotein act as a non-functional receptor for alpha 1-adrenergic antagonists?
    Qin M; Oie S
    J Pharm Pharmacol; 1994 Nov; 46(11):896-901. PubMed ID: 7897595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of plasma protein binding of bupivacaine on its in vivo transfer into the brain and salivary gland of rats.
    Terasaki T; Pardridge WM; Denson DD
    J Pharmacol Exp Ther; 1986 Dec; 239(3):724-9. PubMed ID: 3795038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW; Dewey MJ; Michniak BB; Wiltshire H; Halberg DL; Weigl P; Liang Z; Halifax K; Lindup WE; Back DJ
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.